|
|
||||||||
Discovery Technologies/Diabetes and Metabolism, Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts
Submitted 26 April 2007 ; accepted in final form 9 August 2007
| ABSTRACT |
|---|
|
|
|---|
31P nuclear magnetic resonance spectroscopy; intramyocellular lipids; adenosine triphosphate synthesis; skeletal muscle; insulin resistance
80% glucose disposal) and the primary defect in the insulin-stimulated glucose transport pathway may be lipid related (3, 10, 20, 32, 37, 48), therapeutic strategies aimed at increasing fatty acid oxidation in the muscle present promising targets for future treatments of type 2 diabetes. Mitochondrial oxidation of fatty acids and glucose accounts for the vast majority of ATP generation in healthy skeletal muscles. Not surprisingly, the bioenergetic capacity of skeletal muscle mitochondria is profoundly impaired in type 2 diabetic patients (18, 38, 41). In a perhaps less expected finding, recent clinical data obtained from both elderly patients (29) and offspring of parents with type 2 diabetes (26, 30) have also shown subtle and early defects in mitochondrial oxidative capacity (i.e., due to mitochondrial dysfunction and/or mitochondrial loss), which may lead to an accumulation of intracellular fatty acyl-CoA and harmful metabolites, such as diacylglycerol, that disrupt insulin signaling (16, 35). Furthermore, excess dietary fat may also play a crucial role in the development of mitochondrial dysfunction, as supported by a recent study showing downregulation of genes involved with oxidative phosphorylation and mitochondrial biogenesis in response to high-fat feeding (39).
Building upon these findings, it has been suggested that restoration of mitochondrial activity could help improve insulin sensitivity through enhanced fat oxidation. This type of treatment was shown to be effective on obese patients undergoing therapy involving physical activity (11, 24). Although divergent data occasionally suggest a dissociation between skeletal muscle adaptations and mitochondrial function (28), maximal enzyme activities do not necessarily reflect actual flux through metabolic pathways and consequently may not be sufficiently sensitive to detect the subtle changes in bioenergetic status. In addition, these studies rely on tissue biopsies to measure enzyme activities, allowing only a selected few time points, and often making longitudinal studies unfeasible.
Conversely, 31P magnetic resonance spectroscopy (MRS) provides a noninvasive means to monitor the energetic status of the cell by measuring intracellular phosphorylated metabolites [e.g., ATP and creatine phosphate (PCr)]. However, because of efficient regulation mechanisms, levels of energy metabolites in muscle under nonischemic and resting conditions frequently remain unchanged, making them insensitive indicators for the characterization of a pathological state. Accordingly, it is conceivable that a direct assessment of specific metabolic fluxes would offer a better alternative, with a dynamic range potentially wide enough for drug profiling studies. In this respect, 31P magnetization transfer offers the unique possibility to noninvasively determine certain reaction rates without disturbing the chemical equilibrium, as is often the case when labeled substrates are used. These qualities make this technique particularly effective in measuring reaction rates in vivo such as the one catalyzed by the mitochondrial F1F0 ATP synthase, the terminal step in the oxidative phosphorylation process. Since mitochondrial ATP production is coupled to substrate utilization via a stoichiometric relationship (40), it is reasonable to assume that any change in the ATP synthesis rate will reflect a change in oxidative phosphorylation.
In this context, the primary aim of this study was to investigate the existence of changes in mitochondrial activity that may occur in a diet-induced obesity rat model of insulin resistance. To do so, serial measurements were performed to 1) verify whether muscle ATP synthesis turnover is associated with other relevant markers of insulin resistance, specifically intracellular fat accumulation and glucose tolerance, 2) determine the conditions under which diet-induced changes in muscle ATP synthesis rate are readily reversible, and, finally, 3) assess the compliance of mitochondria in response to high lipid exposure during short-term and long-term high-fat diet regimens.
| METHODS |
|---|
|
|
|---|
All experiments were performed in male rats anesthetized with 2% isoflurane administered via a face mask during NMR data acquisition. Dietary interventions involved controlled modulation between normal chow diet (NC; 4.5% crude fat, Pico Lab Rodent Diet 20 no. 5053i; Lab Diet, Brentwood, MO) and high-fat diet (HF; diet no. D12492 [GenBank] , 60% fat cal; Research Diets, New Brunswick, NJ). All experimental procedures were carried out with the approval of the Novartis Institutional Animal Care and Use Committee.
Study Protocols
Study 1. In the initial study, the interactions between muscle ATP synthesis rates, whole body glucose tolerance, and intramyocellular lipid (IMCL) levels were investigated. To make these comparisons, six Sprague-Dawley rats were fed the HF diet for 10 wk, a situation known to induce peripheral insulin resistance, and were tested against six age-matched rats fed the NC diet.
Study 2. Another cohort of male Sprague-Dawley rats (n = 4) was repeatedly measured for ATP synthesis and IMCL levels while the diet was alternated from NC to HF for 3 wk (note this is less than the 8–10 wk typically accepted to induce insulin resistance) and then back to the NC diet. The main objective of this trial was to test the reversibility of short-term diet-induced changes in muscle mitochondrial function.
Study 3. In the final study, a detailed analysis of the relationship between mitochondrial function and fat storage was performed using ATP flux and IMCL measurements taken at relatively short intervals (i.e., every other day up to once a week) in a cohort of male Wistar rats (n = 6) fed the HF diet for 5 wk. The measurement of the ATP synthesis rate was systematically combined with the measurement of IMCL levels during the same NMR session.
Oral Glucose Tolerance Test
After overnight fasting (16 h), rats were given an oral bolus of glucose (1.0 g/kg), and blood samples were obtained via a tail nick 0, 30, 60, and 120 min after glucose administration. Blood samples (50 µl) were collected in heparinized microcentrifugation tubes (Brinkmann Instruments, Westbury, NY) and were centrifuged at 10,000 rpm for 5 min at 4°C. Plasma glucose concentrations and insulin levels were then measured using a YSI 2700 Dual Channel Biochemistry Analyzer (Yellow Springs Instrument, Yellow Springs, OH) and an ELISA assay kit (American Laboratory Products, Windham, NH), respectively.
The Matsuda insulin sensitivity index (ISI) was also calculated as a composite whole body ISI during the oral glucose tolerance test (OGTT) (ISI[composite]) using the following formula:
![]() | (22) |
In Vivo NMR Setup
All in vivo MR measurements were performed on a Bruker Avance 7.0 T/30 cm wide-bore instrument (Bruker Medical, Billerica, MA) equipped with 20-cm id actively shielded gradient insert. For each time point, two 13-min 31P saturation transfer spectra (i.e., ATP
saturated and unsaturated spectra), six 3.5-min 31P inversion recovery spectra (i.e., T1obs measurement) and one localized 1H-MR spectrum (i.e., IMCL measurement) were acquired. On average, total scan time did not exceed 1.5 h per animal. To collect signal from the lower leg of the rat, both 1H- and 31P-NMR spectroscopy were performed using a dual-frequency 1H/31P 2.5-cm surface coil working in a transmitter/receiver mode and tuned to 300.31 (1H) and 121.57 (31P) MHz.
IMCL measurement.
IMCL contents were measured using a method similar to one presented earlier (19), but with acquisition parameters optimized for the 7T magnet. For each session, the rat was laid prone on a supportive bed, with the left leg positioned over the surface coil, and placed in the magnet isocenter. After global 1H shimming, transverse, sagittal, and coronal scout images (FISP: TE 1.82 ms, TR 3.64 ms, slice thickness 2 mm, field-of-view 35 x 35 mm, 8 averages) were acquired to confirm proper placement for 31P spectroscopic measurements and to carefully position the 2 x 2 x 2 mm3 volume of interest used to measure IMCL content in the left tibialis anterior (TA) muscle, avoiding blood vessels and gross adipose tissue deposits. Following 31P spectra collection, localized shimming was performed on the water signal to achieve typical line widths of
13 Hz. The localized 1H-NMR spectrum was then collected using a PRESS sequence (TE 20 ms, TR 2 s, 4,096 data points over an 8-kHz spectral width, CHESS water suppression, 256 scans).
Measurement of muscle ATP synthesis rate.
The unidirectional ATP production can be assessed noninvasively as initially described for measurements in Escherichia coli (6) and subsequently in the skeletal muscle in rat (5). In this procedure, the ATP
NMR peak is nulled with a saturating radio frequency (rf) pulse, and a reduction in the Pi peak is observed as a result of the transfer of the saturated spins between ATP
and the Pi pool (via the F1F0 ATPase reaction). In contrast to the heart, the glycolytic contribution to ATP synthesis [through e.g., glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 3-phosphoglycerate kinase reactions] can be considered negligible in skeletal muscles for which the Pi
ATP flux is predominantly due to mitochondrial F1F0 ATPase activity (3).
Muscle ATP synthesis rates were measured in rats as previously reported by Jucker et al. (17). Two spectra were acquired for each saturation transfer experiment, one with and one without (control spectrum) steady-state saturation of the ATP
peak. The following acquisition parameters were used: nonselective detection of the intramyocellular 31P signal with a 90° block pulse, 10 kHz sweep width, and 1,024 data points, and selective irradiation of the ATP
resonance was achieved with a low-power continuous wave pulse applied for 5.9 s, a total of 128 averages, each with a 6-s repetition time. During acquisition of the control spectrum, the saturation pulse was placed at a frequency offset equidistant downfield of Pi. The ratio of the resulting magnetization (Mz) to the equilibrium magnetization (M0) in the absence of ATP
saturation is given by the equation:
![]() | (1) |
Despite the relatively fast reaction rate between Pi and ATP
, it is important that the spin-lattice relaxation time (i.e., observed T1obs) be evaluated on an individual basis in the presence of continuous ATP
saturation for accurate measurement. While applying an inversion recovery (IR) pulse during the mixing period, the apparent T1obs is related to T1 by the following equation:
![]() | (2) |
A 2,000-ms sech inversion pulse was applied at inversion delays (TI) of 299, 799, 1,749, 2,999, 4,499, and 5,999 ms from the 90° detection pulse to invert all Pi spins during the ATP
saturation and accurately determine T1obs for all Pi metabolites. Each IR spectrum was constituted of 32 averages, leading to a total experimental time of
20 min. Typical results from an NC rat are summarized in Fig. 1. Individual T1obs values were calculated using a nonlinear least square fitting method based on the following equation:
![]() | (3) |
|
M) used to determine the kinetics of ATPase activity (i.e., the rate constant k) was computed by simultaneously solving Eqs. 1 and 2, yielding the following equation (17):
![]() | (4) |
M = M0 – Mz
The unidirectional ATP synthesis flux was then calculated by multiplying the constant k by the Pi concentration ([Pi]) extrapolated from the baseline NMR spectrum (comparing peak integrals from Pi and ATP
) and using concentrations ([ATP]) as obtained biochemically from calf muscles of 35 normal rats {i.e., [ATP] = 4.39 ± 0.53 µmol/g (2)}. Since changes in the
Pi signal contribute, for the most part, to changes in the calculated value of muscle ATP synthesis rate (i.e., only small variations in T1obs are expected), it was verified that any changes in the muscle ATP synthesis rate were actually matched with changes in corresponding
Pi/
ATP
ratios (results not shown).
Data Analysis
All 31P spectra were processed using XWIN NMR Suite (version 3.2; Bruker Biospin, Karlsruhe, Germany). After applying a 20-Hz line-broadening filter, phasing, and baseline correcting, peak areas were assessed for signals from Pi (4.9 ppm), PCr (0 ppm), and all three ATP (ATP
: –2.4, ATP
: –7.4, and ATP
: –15.9 ppm). To gain sensitivity in the saturation transfer experiment, the saturation-induced change in Pi peak area (
Pi) was assessed after subtracting the ATP
saturated spectrum from the unsaturated control spectrum. IMCL spectra were processed using the Nuts-PPC software package (Acorn NMR, Fremont, CA). Once spectra were line broadened, phased, and baseline corrected, peak areas for total creatine (tCr: 3.02 ppm), EMCLTA (methylene peak at 1.5 ppm), and IMCLTA (methylene peak at 1.3 ppm) were determined using a line-fitting procedure. IMCLTA content was then expressed as a percentage of tCr content.
Statistics
Where applicable, intergroup comparisons were made using a two-tailed, nonpaired Student's t-test or a two-way repeated-measures analysis of variance and simultaneous pairwise multiple comparison procedures (Holm-Sidak method). Data are presented as means ± SE, and P < 0.05 was considered statistically significant.
| RESULTS |
|---|
|
|
|---|
Figure 2 displays the variations observed between a rat on the HF diet for 10 wk and an age-matched NC control. For each rat, the presented spectrum shows the difference observed between the unsaturated and the ATP
-saturated spectra. Although saturation of the ATP
peak was maximally effective in both cases, the loss of Pi signal was clearly greater for the NC rat than the rat fed the HF diet. Analysis of signal quality showed SNR values consistently in the range of 10–12 for rats fed an NC diet [using SNR = (2.5 x peak height)/peak-to-peak noise]. Assuming an SNR with a threshold value of 3 or greater for accurate measurement, this would theoretically give a dynamic range of
75% for assessment of the muscle ATP synthesis flux between a nonpathological and a pathological model. For relatively constant Pi relaxation times (T1obs), this would translate into ATP synthesis flux values between
3 and
18 µmol·g–1·min–1. Ten weeks on the HF diet resulted in a
35% decrease in ATP synthesis rate (Fig. 3). A positive linear correlation with a slope of
1 with 10 ± 7% deviation from the mean was found during a test-retest study, indicating an excellent intraindividual reproducibility of ATP synthesis rate measurements (data not shown). Overall, actual rates obtained for muscle ATP synthesis in rats at rest are in excellent agreement with recent human data (36). After the 10-wk regimen, rats fed the HF diet also exhibited significantly higher body weights (data not shown) and IMCL levels (Fig. 3), supporting an obesity phenotype. At this time, an OGTT was also performed to determine whether the diet change triggered an insulin-resistant state. Areas under the curves (AUCs) for both glucose and insulin excursion data doubled (P < 0.05) in HF-fed rats relative to their NC-fed counterparts (Fig. 3), indicative of significant HF diet-induced glucose intolerance, a prediabetic condition. As expected, the HF diet also induced a significant impairment of whole body insulin sensitivity, as estimated under fasting by the Matsuda index (Fig. 3).
|
|
Figure 4 illustrates the time-course variations observed both in muscle ATP synthesis rates and in IMCL levels while the fat content in the diet was modulated. Upon induction of the HF diet, a drastic drop in mitochondrial activity was observed (
38% decrease in muscle ATP synthesis rate, P < 0.05). The changes in ATP synthesis rate measured after 5 days on the HF diet were accompanied by a sharp increase, almost fourfold, in IMCL storage. This change is likely to be a result of both an increased fatty acid uptake and decreased utilization (i.e., due to a defect in lipid oxidation). At day 21, the ATP flux appeared to return to normal values, and, even though dietary fat ingested remained elevated, IMCL stores were maintained at levels similar to those measured at day 5. Returning to the NC diet resulted in a rapid decline of IMCL contents (i.e., back to baseline levels in less than 2 days) without a concomitant change in muscle ATP synthesis rates. Two days later (day 25), the variables analyzed showed some divergence: muscle ATP synthesis drastically decreased by 27% while IMCL contents remained low. Also, no increase in body weight was observed during this 5-day transition period, suggesting that caloric intake was kept relatively low immediately after switching back to the NC diet (Fig. 4). This disconnect was only temporary, and within 2 wk the inverse relationship between the ATP synthesis rate and IMCL levels was again observed.
|
Here, we examined in more detail the time-course variations in muscle mitochondrial activity of rats on the HF diet for 5 wk. Unpublished in-house data demonstrate relative steadiness in muscle ATP synthesis rates and IMCL contents in rats on an NC diet up to 20 wk of age that were comparable to the baseline values measured in this study. Therefore, by comparing the time-course changes with the baseline values, each rat served as its own control, thus eliminating the need for comparisons with animals on an NC diet. Figure 5 shows a typical 1H spectrum series obtained in vivo from a single rat illustrating IMCL changes over the course of the study. Thanks to repeated measurements performed at relatively short time intervals, several phases in the response could be clearly identified during this period of altered diet both in terms of IMCL and muscle ATP synthesis rates (Fig. 6). After only 24 h on the HF diet (phase I), rats responded in an acute fashion with drastic lowering of the muscle ATP synthesis rate (–45%, P < 0.05 vs. baseline) and a concomitant increase in IMCL content (
3-fold, P < 0.05 vs. baseline). Beyond the first day (phase II), rats gradually regained mitochondrial activity while accumulating IMCL at a much slower pace, reaching maximum after 7 days (IMCL/tCr ratio of
2.8, P < 0.05 vs. baseline). More succinctly, the increment in IMCL contents decreased as the ATP synthesis rate gradually returned toward baseline levels. During the subsequent 2 wk (phase III), both the ATP synthesis rate and IMCL contents remained constant, indicating the existence of a new metabolic steady state. This temporal equilibrium was characterized by an ATP flux slightly below the baseline value (
20%, not significant) in conjunction with relatively high IMCL levels. However, beyond 3 wk on the HF diet, the steady state gave way to a slow but stable decrease in muscle ATP synthesis rate with levels reaching
60% of the baseline value at week 5 (P < 0.05). Concurrently (from weeks 3 to 5), IMCL contents regularly increased to levels six- to sevenfold greater than the baseline values. Body weight gain in these animals remained steady despite such variations (Fig. 6).
|
|
| DISCUSSION |
|---|
|
|
|---|
The diet-induced reduction in the rate of ATP synthesis fits nicely with a recent report (14), which showed a significant decrease in the respiratory capacity of the hindleg muscles from isolated mitochondria of adult rats under similar feeding conditions. Of note, these same authors had earlier revealed a completely contradictory picture in young rats (i.e., 30 days of age), in which high-fat feeding resulted in increased mitochondrial capacity to employ lipids as metabolic fuel (15). This parallels the accepted notion that adult rats are more prone to obesity than younger rats, which may benefit from adaptive thermogenesis to counteract diet-induced obesity (34). Whether high-fat feeding elicits a decline in the metabolic activity of adult rats through a decrease in mitochondrial mass and/or specific activit or by some other unknown meachnism, in a similar fashion to the aging process (1) remains to be determined.
Results obtained from the second experiment illustrated the high compliance of the mitochondrial system with variations in fat availability. The initially observed decrease in mitochondrial activity revealed itself to be transient, and consequently IMCL levels steadied as the ATP synthase flux rate recovered to baseline values. Speculatively, this may indicate that excessive fat storage can be temporarily barred by efficient oxidative phosphorylation despite augmented availability of circulating fat. This would imply that any new fatty acid entering the cell would be oxidized, preventing further lipid accumulation within the cell. This points to an adaptive mechanism that would allow the rat to still effectively counteract obesity at this time. This theory is in agreement with data showing significant increases in enzyme activity for fatty acid oxidation in muscles of adult rats maintained on a high-fat diet for 4 wk (27). As these should require time, one can speculate that the sharp rise in IMCL contents during this transition period results from both a lipid mass effect and a transient decrease in mitochondrial activity, the latter being directly or indirectly caused by inhibitory lipid intermediates. This may also partially explain why short-term consumption of a high-fat diet often results in only a mild impairment of whole body glucose tolerance, a defect likely to be hepatic in origin (9, 21). It also reconfirms the notion that, beyond the relative amount and nature of ingested fat (see example in Ref. 47), the length of the regimen obviously plays a crucial role as a dietary factor affecting the metabolic phenotype of muscle in a sustained fashion. Thus, depending on the model required, adult rats would need to be maintained on a high-fat diet for a minimum of 4 wk before showing clear signs of muscle insulin resistance (21).
The return to a normal chow diet prompted a rapid decline of IMCL contents, returning to baseline levels in less than 2 days, without concomitant change in muscle ATP synthesis rates. This supports the previous assertion that fully efficient oxidative phosphorylation attacks previously stored lipids (i.e., IMCL contents in the form of lipid droplets) as main substrates when new lipids entering muscle cells are scarce, thus returning the situation to one similar to that depicted under baseline conditions. However, 2 days later, the data showed some divergence: muscle ATP synthesis drastically decreased by 27% while IMCL contents remained low. One possible explanation is that mitochondrial activity temporally disconnects itself from lipid substrates by some unknown mechanism in times of short supply. As such, there was no change in body weight during the 5-day transition period, suggesting that caloric intake did not increase shortly after switching back to the normal chow diet. In other words, muscle fat oxidation decreased while lipids were, at that time, scarce as metabolic fuels. The lack of information on plasma glucose, insulin, and lipid profiles certainly limits our interpretation of these data, and additional studies would be needed to support such an assumption. However, one should note that this disconnect was only temporary, as within 2 wk the inverse relationship between the ATP synthesis rate and IMCL levels was again observed.
In our first experiment, the 10-wk HF regimen clearly resulted in an obesity phenotype, considering that IMCL contents almost doubled (P < 0.05) between 3 wk (IMCL/tCr = 3.45 ± 1.20) and 10 wk on the HF diet (IMCL/tCr = 6.44 ± 1.43). This could indicate a continuous "blunting" of ATP synthesis that resulted in a cumulative effect on intramyocellular fat accumulation. Our third experiment looked at periodic changes in the ATP synthesis flux in greater detail to help explore that hypothesis. Overall, the data obtained from this latter study support the possible existence of an intimate relationship between substrate (i.e., fat) availability and efficiency of utilization by the "burning factory" (i.e., muscle), as previously observed in healthy (4), prediabetic (30), and type 2 diabetic patients (36). Although the underlying molecular mechanism responsible for the initial inhibitory effect of intracellular lipids on oxidative phosphorylation remains to be elucidated, these results unambiguously demonstrate the capacity of the mitochondrial system to recover and preserve its function as long as
3 wk with chronic exposure to high-fat food. These data are well aligned with previous results obtained from DIO (diet-induced obese) rodent models showing that at least one month on a high-fat diet is required to generate significant impairment in glucose tolerance (Ref. 13 and unpublished data), muscle insulin sensitivity (12), or muscle insulin signaling (31). This suggests an adaptive mechanism, which could, in part, explain why elevated dietary fat does not necessarily result in a drastic drop of oxidative enzyme activities (8, 42). It is possible that such a mechanism involves the mitochondrial uncoupling protein-3, which when induced under high-fat conditions (46) could protect mitochondria against lipid-induced oxidative damage (25) and help restore fatty acid oxidation to a normal level. However, this new equilibrium, which is usually not associated with insulin resistance in rats, appeared to be a transient phenomenon, since prolonging the high-fat diet beyond 3 wk resulted in a progressive degradation of muscle mitochondrial function and a steady increase in fat storage, as was recently shown (7). As suggested above, this latter transition phase may be associated with the appearance of an insulin resistance phenotype.
Assuming no change in physical activity, the fate of the extra ATP generated in response to an increase in mitochondrial activity (as observed for example during phase II in study 3) is unclear. Our hypothesis is that ATP production through nonoxidative glycolysis is decreased whereas proper mitochondrial activity is restored, which would preserve the balance between energy demand and supply. On the contrary, this pathway is not completely suppressed during insulin infusion in non-insulin-dependent diabetic patients (45). Such a hypothesis warrants further investigation.
To our knowledge, apart from indirect calorimetry, which is more global and provides little dynamic range, there is no gold standard against which the ATP synthesis rate measured by 31P saturation transfer can easily be validated. As mentioned earlier, maximal activity of the ATP synthase, which can only be determined in vitro, may not necessarily match with the actual flux measured in vivo. The same holds true for tricarboxylic acid cycle enzymes such as succinate dehydrogenase or citrate synthase. Since a reduction in mitochondrial density is associated with insulin resistance (26), one could consider measuring muscle cardiolipin, a known tissue marker of mitochondrial capacity, from tissue extracts (23, 43), except that the exact biological function of cardiolipin remains elusive. Conversely, muscle mitochondrial activity depends not only on the density and functionality of mitochondria but also on the supply of oxygen and substrate. In the present studies, ATP synthesis rate measurements were restricted to a resting state, i.e., dealing with basal metabolism. The fact that resting energy expenditure contributes to two-thirds of daily energy expenditure was the main justification for choosing this context. As a matter of fact, body weight regulation (and to some extent insulin resistance as well) mostly involves adjustment of the ratio of energy intake to resting energy expenditure, and as a result, fat balance is considered the main determinant of resting energy balance in obesity (44). Incorporating exercise into the assay to exacerbate this balance mechanism may help improve the dynamic range of the ATP turnover measurement. Such implementation, however, would require exercise to be performed under isometric conditions to minimize motion (and artifacts in the NMR spectrum) while maintaining strict control of the workload and tissue oxygenation (i.e., nonischemic exercise). Another possibility would be to test rats in response to an insulin challenge (clamp), which is known to enhance mitochondrial activity (4, 30).
In summary, these results demonstrate that mitochondrial activity is highly responsive to diet changes. Data showed a rapid reduction in ATP synthesis within a few days of raising fat in the diet. However, metabolic compliance in the rat muscle appears to be such that ATP synthesis can be restored and maintained at a normal rate up to 2–3 wk on the high-fat regimen, most likely to combat further accumulation of fat in skeletal muscles, this possible explanation being supported by our IMCL measurements. It is only beyond one month of exposure to high fat that a steady decrease in ATP synthesis rate is consistently observed. Although intergroup differences in ATP synthesis do not appear to be hindered by anesthesia, in vivo measurements using a combination of 31P saturation transfer and localized 1H-MRS may prove particularly useful for a better understanding of muscle insulin resistance, specifically the recent notion (33) of the vicious cycle that seems to exist between excessive fat storage in the muscle and a decrease in mitochondrial activity. Although the underlying mechanism that could explain how high lipid availability can change the rate of muscle ATP synthesis still warrants further investigation, these data may help define a novel readout and appropriate conditions to test mitochondrial activity as a therapeutic target for new antidiabetic drugs.
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Laurent Reply to Kemp: a clarification on the interpretation of muscular ATP synthase flux data obtained by 31P saturation transfer Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E643 - E644. [Full Text] [PDF] |
||||
![]() |
G. J. Kemp The interpretation of abnormal 31P magnetic resonance saturation transfer measurements of Pi/ATP exchange in insulin-resistant skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E640 - E642. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |